Comprehensive translational EU funded doctoral network harnessing lipid metabolism to improve prostate cancer management and educate young researchers.
Leuven, Belgium
Joined June 2024
- Tweets4
- Following41
- Followers18
- Likes5
PROSTAMET_MSCA retweeted
I am happy to share our review on #prostatecancer #epigenetics published in the last issue of @NatRevUrol
pubmed.ncbi.nlm.nih.gov/3982…
#CIIPOP
@GEBC_IPOPorto
@IPOPorto
@Uroweb
@EACR
@AACR
@isMOCLEP
@PROSTAMET
@ASPICancro
@apurologia
@SociedadeSpo
ALT Evolution of prostate cancer (PCa) and associated epigenetic changes at different disease stages (localized PCa, castration-resistant PCa (CRPC), and neuroendocrine PCa), along with potential epidrug classes for administration in CRPC and neuroendocrine PCa stages. Abbreviations: BET - Bromodomain and extraterminal motif; CRPC – Castration-resistant Prostate Cancer; DNMT - DNA methyltransferases; Epidrug – Epigenetic drug; HAT - Histone acetyltransferases; HDAC - histone deacetylases; LncRNA – long non-coding RNA; miRNA- microRNA; PCa – Prostate Cancer.
PROSTAMET_MSCA retweeted
We are pleased to announce the Kick-off meeting of the MSCA-DN PROSTAMET this week in Toulouse. Exciting scientific sessions and training as well as networking.
🚀 We're excited to introduce PROSTAMET, an MSCA EU-funded Doctoral Network dedicated to improving prostate cancer management through lipid metabolism research.
#ProstateCancer #PhD #MSCA #LipidMetabolism #PrecisionMedicine #ResearchAndTraining